M&A Deal Summary

Abattis Bioceuticals Acquires Green Tree Therapeutics

On January 11, 2018, Abattis Bioceuticals acquired medical products company Green Tree Therapeutics

Acquisition Highlights
  • This is Abattis Bioceuticals’ 1st transaction in the Medical Products sector.
  • This is Abattis Bioceuticals’ 1st transaction in Canada.
  • This is Abattis Bioceuticals’ 1st transaction in British Columbia.

M&A Deal Summary
Date 2018-01-11
Target Green Tree Therapeutics
Sector Medical Products
Buyer(s) Abattis Bioceuticals
Deal Type Add-on Acquisition

Target

Green Tree Therapeutics

Vancouver, British Columbia, Canada
Green Tree Therapeutics Corp. is focused on designing and selling branded cannabis products. Green Tree Therapeutics is based in Vancouver, British Columbia.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abattis Bioceuticals

Langley, British Columbia, Canada
Category Company
Sector Life Science
DESCRIPTION

Abattis Bioceuticals Corp. is a life sciences and biotechnology company which aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada.

DEAL STATS #
Overall 1 of 4
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 1 of 3
State (British Columbia) 1 of 2
Country (Canada) 1 of 2
Year (2018) 1 of 3
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-01 CannaNUMUS Blockchain

United States

CannaNUMUS Blockchain, Inc. is a developer of cryptocurrency.

Buy -
Mergr

Product

Company

Legal